Immupharma Share Discussion Threads

[che7win] 19/1/2018 12:11

I'm buying here and IDP today.

I posted an evaluation on IDP this morning on that board - it looks ridiculously cheap as a GARP stock.

[lukead] 19/1/2018 12:08

Remarkomsoc, remarkable insight to your postings, maybe you are an attention seeker as the skinny tan tubes may be back in fashion by the spring

[qs99] 19/1/2018 12:08

Have balanced mine out NYBOY with adding to my SHG gold bet.....totally off topic but as you mentioned balance.....

[top tips] 19/1/2018 12:07

Lupuzor is one of those products where, if they lower the price, it could increase the number of lupus sufferers who use it. So if instead of $25k to $35k pa, it was marketed at $20k pa, take-up could be 1.5+ million = $30 billion pa sales.

Think of 9+ indications, not just lupus, and the potential is huge (even bigger for arthritis).

[ny boy] 19/1/2018 12:05

Right, nothing more to do here, all going v well indeed.

Back to accumulating (NUOG), have been since 0.9p, adding a few more (VRS) & (SHP) going well since yesterday’s 3420p support bounce, everyone loves a cheap pharma!

[che7win] 19/1/2018 12:05

£30 seems a feasible target per share.

[che7win] 19/1/2018 12:04

These are getting like hen's teeth to buy - I really struggled to get some just now.

[aussieb3] 19/1/2018 12:00

Would be great spmc but a price between 15 and 50 would be more like it . If we get taken over

[ny boy] 19/1/2018 11:59

Spmc..

I’ll not sell for less than £2007 a share 😁

[divmad] 19/1/2018 11:48

so do the words "bottom drawer".

[spmc] 19/1/2018 11:45

Tim said in the interview:
"I am really excited that in a relatively short period of time, we could have a drug [Lupuzor] on the market which would benefit literally millions of patients across the world for a condition for which they havn't had an effective treatment ever..."
So he's saying the drug if approved will be taken by millions of people, I better adjust my forecasts I was assuming a few hundred thousand at best. If 2 million people take it at $35k each pa that's $70 billion pa in revenue, a 35% royalty on that will give us $24.5 billion. put that on a normal p/e of 15 gives us a market
cap of $367 billion or £2,006 per share wow :)

[hamhamham1] 19/1/2018 11:43

When it comes to IMM shares, the words 'hens teeth' spring to mind.

[stealth wealth] 19/1/2018 11:19

I entirely agree hottingup.


hottingup
19 Jan '18 - 10:45 - 10259 of 10265

stealth wealth - IMM's Lupuzor and other treatments derived from IMM's P140 platform (there are at least nine and the list is growing) could probably attract revenues of $15 billion+ based on what Abbvie, Amgen/Pfizer, J&J and others have achieved for immunology drugs, even with side effects which we lack.



Add in IMM's other blockbusters in the pipeline - Nucant & URELIX, and it soon mounts up.

[hamhamham1] 19/1/2018 11:08

You could always use it for motivational purposes, for those down days or before big meetings.
Instead of standing in front of the mirror and saying "You're a tiger... ggggrrrrr".
Stand in front of the mirror and saying "You're an Immupharma share holder... ggggrrrrr".

[hamila01] 19/1/2018 10:50

Many of us investors (as opposed to traders) saw the potential years ago and have sat patiently. I've been invested for nearly 5 years now and have got a very good average and a good profit as a result.I appreciate the II's are not going to invest for as long as a PI but they could have got in months ago when the price was sub £1.So I now look at the share price manipulation to fill an order at about £1.50 and have to laugh. Someone's playing games over getting a share 10p or so cheaper when they could have bought at 50-60p not that long ago....Warren Buffett certainly had it right when he talked about the stock market and patience.....

[mad foetus] 19/1/2018 10:50

Topped up. GLA

[hamhamham1] 19/1/2018 10:47

Will be interesting to see how many other brokers initiate coverage on Immupharma over the coming weeks and months.
Am sure there must be a fair bit of snobbery about identifying any promising stocks early in their success?
Once everyone is following them its soo boring, "I much prefer their earlier work!" :)

[hottingup] 19/1/2018 10:45

stealth wealth - IMM's Lupuzor and other treatments derived from IMM's P140 platform (there are at least nine and the list is growing) could probably attract revenues of $15 billion+ based on what Abbvie, Amgen/Pfizer, J&J and others have achieved for immunology drugs, even with side effects which we lack.



Add in IMM's other blockbusters in the pipeline - Nucant & URELIX, and it soon mounts up.

[ny boy] 19/1/2018 10:40

I’ve been sitting comfortably since 52p

Add in the 90’s, 120’s & 150p

Enjoy, the newsflow just got better yesterday!

[hamila01] 19/1/2018 10:37

Yes hamhamham1, this really isn't a share to trade. One to buy in at a certain level and then watch and wait.

[onjohn] 19/1/2018 10:34

I think about ten pounds a share by Marchand shiver in ecstacy